CLINICAL_TRIALS
trial_result
· 2022-11-21
Clinical Trial Update: Study of Jitongning Tablet to Treat Spondyloarthritis [Phase 2]
Summary
Phase 2 trial of Jitongning Tablet for spondyloarthritis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tasly Pharmaceutical Group Co., Ltd | Conditions: Spondyloarthritis | Phase 2 | Status: COMPLETED